The observation that azithromycin could potentially reduce BOS by reducing neutrophilia as well as IL-8 production [70] is sustained by in vitro work, showing inhibition of IL-17-induced IL-8 release from human airway smooth muscle cells when treated with azithromycin [71]. The gene discussed is IL17A; the disease is Buschke-Ollendorff syndrome.